NASDAQ
21.07.25 | 17:34
12,085 US-Dollar
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12.06. | Brainsway stock holds Buy rating as accelerated depression therapy shows promise | 2 | Investing.com | ||
| 11.06. | BrainsWay reports promising results for accelerated depression treatment | 1 | Investing.com | ||
| BRAINSWAY Aktie jetzt für 0€ handeln | |||||
| 11.06. | BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD) | 133 | GlobeNewswire (Europe) | BURLINGTON, Mass. and JERUSALEM, June 11, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders... ► Artikel lesen | |
| 11.06. | Brainsway Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 10.06. | BrainsWay Announces Gold Sponsorship at the 2025 Clinical TMS Society Annual Meeting in San Diego | 1 | GlobeNewswire (USA) | ||
| 09.06. | H.C. Wainwright maintains Buy rating on Brainsway stock | 3 | Investing.com | ||
| 05.06. | BrainsWay invests $5M in Stella Mental Health to expand access to Deep TMS therapy | 1 | MassDevice | ||
| 05.06. | BrainsWay Invests $5 Mln In Stella To Expand Access To Advanced Neurostimulation Therapy | 2 | RTTNews | ||
| 04.06. | BrainsWay invests $5 million in Stella Mental Health | 1 | Investing.com | ||
| 04.06. | BrainsWay Announces $5 Million Minority-Stake Investment in Stella MSO, LLC | 1 | GlobeNewswire (USA) | ||
| 04.06. | Brainsway Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 27.05. | BrainsWay stock holds $16 target, Buy rating at H.C. Wainwright | 1 | Investing.com | ||
| 13.05. | Brainsway Inc. Q1 Earnings Summary | - | RTTNews | ||
| 13.05. | BrainsWay GAAP EPS of $0.02 in-line, revenue of $11.54M beats by $0.09M | 1 | Seeking Alpha | ||
| 13.05. | BrainsWay Reports First Quarter 2025 Financial Results and Operational Highlights | 152 | GlobeNewswire (Europe) | Achieved record quarterly sales of $11.5 million in Q1 2025, an increase of 27% compared to Q1 2024 Operating profit totaled $0.6 million and Adjusted EBITDA rose to $1.3 million, increasing by... ► Artikel lesen | |
| 13.05. | Brainsway Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 12.05. | BrainsWay Q1 2025 Earnings Preview | 1 | Seeking Alpha | ||
| 22.04. | BrainsWay files to sell up to 3.6M American Depositary Shares for holders | 3 | Seeking Alpha | ||
| 11.03. | BrainsWay Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights | 223 | GlobeNewswire (Europe) | Achieved record quarterly sales of $11.4 million in Q4 2024, an increase of 27% compared with Q4 2023 Full year 2024 revenue increased nearly 30% YoY to $41 million Exceeded full year 2024 operating... ► Artikel lesen | |
| 11.03. | BrainsWay GAAP EPS of $0.04 beats by $0.02, revenue of $11.41M beats by $0.52M | 2 | Seeking Alpha |
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 45,680 | -0,26 % | Siemens Healthineers: Die Entscheidung rückt näher | Seit Ende Mai läuft die Siemens Healthineers-Aktie in einer engen Spanne seitwärts. Zuletzt wurde der Kurs durch ein stetes Für und Wider in diesem Käfig gehalten. Aber spätestens mit den näher rückenden... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 50,35 | -0,69 % | ANALYSE-FLASH: RBC lässt Carl Zeiss Meditec auf 'Sector Perform' - Ziel 60 Euro | NEW YORK (dpa-AFX) - Die kanadische Bank RBC hat die Einstufung für Carl Zeiss Meditec mit einem Kursziel von 60 Euro auf "Sector Perform" belassen. Analyst Jack Reynolds-Clark sieht laut seinem am... ► Artikel lesen | |
| ECKERT & ZIEGLER | 64,70 | -2,34 % | EQS-News: Eckert & Ziegler SE: Ausbildungsqualität erneut ausgezeichnet | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Sonstiges
Eckert & Ziegler: Ausbildungsqualität erneut ausgezeichnet
15.07.2025 / 14:00 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen | |
| UNITEDHEALTH | 242,95 | +0,64 % | Bank-Bilanzen im Fokus - Bitcoin, Nel, United Health, ASML, Goldman Sachs, BoA, Johnson & Johnson | Die Wall Street beendete den gestrigen Handelstag uneinheitlich. Während Standardwerte kaum gefragt waren, sorgte erneut der Technologiebereich für Bewegung. Der Nasdaq 100 stieg zur Eröffnung auf ein... ► Artikel lesen | |
| TELADOC HEALTH | 7,280 | +2,09 % | Teladoc launches Wellbound, an employee assistance program that leverages BetterHelp | ||
| HIMS & HERS HEALTH | 41,230 | +1,13 % | Hims & Hers nach Aus mit Novo Nordisk: "Erhöhtes Risiko von Rechtsstreitigkeiten" | Wie gewonnen, so zerronnen: Zunächst entfachte die umfangreiche Zusammenarbeit zwischen dem Telehealth-Unternehmen Hims & Hers und dem Biopharma-Riesen Novo Nordisk jede Menge Euphorie. Doch dann kam... ► Artikel lesen | |
| ALCON | 74,66 | +0,05 % | Alcon's Unity VCS Gets Health Canada Approval | OTTAWA (dpa-AFX) - Alcon, Inc. (ALC) announced Tuesday that UNITY Vitreoretinal Cataract System (VCS) has received Health Canada approval. This innovation is the first to be introduced from... ► Artikel lesen | |
| RESMED | 225,60 | +0,98 % | Analyst Expectations For ResMed's Future | ||
| AMBU | 13,160 | +1,46 % | Ambu A/S: Interim Report For Q2 2024/25 And The Half-year | 7.5.2025 07:00:01 CEST | Ambu A/S |
Half Year financial report
In the second quarter of the 2024/25 financial year, Ambu delivered 11.7% organic revenue growth and a 14.4% EBIT margin before special... ► Artikel lesen | |
| LIFEWARD | 0,760 | +2,98 % | Lifeward Ltd.: Administrative Law Judge Determines ReWalk Personal Exoskeleton is "Reasonable and Necessary" for Medicare Beneficiary | MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, June 24, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform... ► Artikel lesen | |
| BONESUPPORT | 28,080 | -3,04 % | Bonesupport Holding AB: Bonesupport Holding AB (publ) - Publishes Q2 2025 Interim Report | BONESUPPORT HOLDING AB (publ), a leading company in orthobiologics for the management of bone injuries, today publishes the interim report for the second quarter 2025.
CONTINUED STRONG GROWTH IN THE... ► Artikel lesen | |
| ICON | 134,00 | +12,18 % | ICON plc: ICON's Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report | ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research organisations (CRO) for phase 1... ► Artikel lesen | |
| TELEFLEX | 95,00 | +1,06 % | Teleflex Stock: A Deep Dive Into Analyst Perspectives (5 Ratings) | ||
| DELCATH SYSTEMS | 9,650 | -0,52 % | Delcath Systems Targets Positive Adj. EBITDA In Each Quarter Of 2025 | WASHINGTON (dpa-AFX) - Delcath Systems (DCTH) said its financial outlook for fiscal 2025 is: total CHEMOSAT and HEPZATO KIT revenue of $94 to $98 million, an increase of more than 150% over... ► Artikel lesen | |
| ORASURE TECHNOLOGIES | 2,760 | -0,72 % | OraSure Technologies, Inc.: OraSure to Announce Second Quarter 2025 Financial Results and Host Earnings Call on August 5th |
Das Unternehmen BRAINSWAY LTD ADR kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 12,085 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BRAINSWAY LTD ADR finden Sie auf Wallstreet Online.